Sarepta Therapeutics
Price & Volume
Stats
See moreOpen | $53.17 |
Previous Close | $51.03 |
Day Range | $51.39-$54.64 |
52W Range | $48.01-$173.25 |
Market Cap | $4.9B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $1.9B |
Revenue Growth (YoY) | 65.9% |
Gross Profit (12 Mos) | $778.3M |
Diluted EPS | $2.34 |
News
See moreYahoo Finance • 2 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
Yahoo Finance • 7 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
Yahoo Finance • 7 days ago
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
Yahoo Finance • 11 days ago
Sarepta/Roche Suspend Elevidys Gene Therapy Trials In Europe After Patient Death
About
CEO | Mr. Douglas S. Ingram Esq. |
CFO | Mr. Ian Michael Estepan |
Address | 215 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,372 |
